In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary

Peter Tajti1,2, Dimitri Karmpaliotis3, Khaldoon Alaswad4

  • 1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (P.T., M.N.B., I.X., L.I.S., B.V.R., E.S.B.).

Insights

Patients with prior coronary artery bypass graft surgery undergoing chronic total occlusion interventions had lower success rates but similar complication risks. However, mortality was higher, while tamponade incidence was lower in this group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Chronic total occlusion (CTO) percutaneous coronary interventions (PCI) are complex procedures.
  • Patients with prior coronary artery bypass graft surgery (CABG) present unique challenges for CTO PCI.

Purpose of the Study:

  • To evaluate the procedural outcomes of CTO PCI in patients with prior CABG.
  • To compare clinical and angiographic characteristics and outcomes between patients with and without prior CABG undergoing CTO PCI.

Main Methods:

  • A large multicenter registry of 3486 CTO interventions was analyzed.
  • Patients were stratified into two groups: those with prior CABG (n=1101) and those without (n=2317).
  • Clinical data, angiographic characteristics, procedural techniques, and in-hospital outcomes were compared.

Main Results:

  • Prior CABG patients were older, had more comorbidities, and lower ejection fraction.
  • Higher J-CTO and PROGRESS-CTO scores were observed in the prior CABG group, indicating greater lesion complexity.
  • Retrograde and antegrade dissection reentry techniques were used more frequently in prior CABG patients.
  • Technical and procedural success rates were lower in prior CABG patients (84% and 82%, respectively) compared to those without (89% and 87%).
  • In-hospital mortality (1% vs 0.4%) and coronary perforation (7.1% vs 3.1%) were higher in prior CABG patients.
  • Incidence of pericardial tamponade (0.1% vs 1.0%) and pericardiocentesis (0% vs 1.3%) was lower in prior CABG patients, despite similar overall major complication rates (3.1% vs 2.5%).

Conclusions:

  • Prior CABG patients undergoing CTO PCI experience lower procedural success rates.
  • While overall in-hospital complication risks are similar, mortality is higher in prior CABG patients.
  • Specific complications like tamponade are less frequent in prior CABG patients, suggesting differences in procedural management or patient factors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
658